• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Retraction notice to "Knockdown of lncRNA XIST inhibits retinoblastoma progression by modulating the miR-124/STAT3 axis" [Biomed. Pharmacother. 107(2018) 547-554].

作者信息

Hu Chunmei, Liu Shu, Han Mei, Wang Yingxue, Xu Chunling

机构信息

Department of Tumor and Hematology, The Second Hospital of Jilin University, Nanguan District, Changchun, Jilin 130041, PR China.

Department of Ophthalmology, The Second Hospital of Jilin University, Nanguan District, Changchun, Jilin 130041, PR China.

出版信息

Biomed Pharmacother. 2022 May;149:112795. doi: 10.1016/j.biopha.2022.112795. Epub 2022 Mar 11.

DOI:10.1016/j.biopha.2022.112795
PMID:35282972
Abstract
摘要

相似文献

1
Retraction notice to "Knockdown of lncRNA XIST inhibits retinoblastoma progression by modulating the miR-124/STAT3 axis" [Biomed. Pharmacother. 107(2018) 547-554].对“敲低lncRNA XIST通过调节miR-124/STAT3轴抑制视网膜母细胞瘤进展”[《生物医学与药物治疗》107(2018) 547 - 554]的撤稿通知
Biomed Pharmacother. 2022 May;149:112795. doi: 10.1016/j.biopha.2022.112795. Epub 2022 Mar 11.
2
Retraction notice to "Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma" [Biomed. Pharmacother. 109 (2019) 798-805].
Biomed Pharmacother. 2022 Jun;150:112855. doi: 10.1016/j.biopha.2022.112855. Epub 2022 Mar 25.
3
Retraction notice to: "LncRNA DANCR silence inhibits SOX5-medicated progression and autophagy in osteosarcoma via regulating miR-216a-5p" [Biomed. Pharmacother. 122 (2019) 109707].
Biomed Pharmacother. 2023 Oct;166:114876. doi: 10.1016/j.biopha.2023.114876. Epub 2023 Jun 21.
4
Retraction notice to "Long noncoding RNA SNHG16 promotes human retinoblastoma progression via sponging miR-140-5p" [Biomed. Pharmacother. 117 (2019) 109153].
Biomed Pharmacother. 2022 Jun;150:112857. doi: 10.1016/j.biopha.2022.112857. Epub 2022 Mar 25.
5
Retraction notice to: "LncRNA SNHG3 promotes the growth and metastasis of colorectal cancer by regulating miR-539/RUNX2 axis" Biomed. Pharmacother. 125 (2020) 110039.撤回通知：“LncRNA SNHG3通过调控miR-539/RUNX2轴促进结直肠癌的生长和转移”，《生物医学与药物治疗》，125卷（2020年），第110039页 。
Biomed Pharmacother. 2023 Oct;166:114877. doi: 10.1016/j.biopha.2023.114877. Epub 2023 Jun 21.
6
Retraction notice to "LNCRNA CDKN2B-AS1 regulates mesangial cell proliferation and extracellular matrix accumulation via miR-424-5p/HMGA2 axis" [Biomed. Pharmacother. 121 (2020) 109622].
Biomed Pharmacother. 2023 Aug;164:114728. doi: 10.1016/j.biopha.2023.114728. Epub 2023 Apr 20.
7
RETRACTED: Knockdown of lncRNA XIST inhibits retinoblastoma progression by modulating the miR-124/STAT3 axis.撤回：通过调节 miR-124/STAT3 轴抑制长链非编码 RNA XIST 抑制视网膜母细胞瘤的进展。
Biomed Pharmacother. 2018 Nov;107:547-554. doi: 10.1016/j.biopha.2018.08.020. Epub 2018 Aug 13.
8
Retraction notice to "Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ROCK2 axis" [Biomed. Pharmacother. 125 (2020) 109882].撤回声明：“长链非编码RNA TTN-AS1通过调节miR-139-5p/ROCK2轴促进卵巢癌肿瘤发生”[《生物医学与药物治疗》125卷（2020年）109882页]
Biomed Pharmacother. 2022 Sep;153:113356. doi: 10.1016/j.biopha.2022.113356. Epub 2022 Jul 11.
9
Retraction notice to "lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer" [Biomed. Pharmacother. 114 (2019) 108814].
Biomed Pharmacother. 2022 Jan;145:112511. doi: 10.1016/j.biopha.2021.112511. Epub 2021 Dec 9.
10
Retraction notice to "MiR-539 inhibits human colorectal cancer progression by targeting RUNX2″ [Biomed. Pharmacother. 95 (2017) 1314-1320].
Biomed Pharmacother. 2023 Nov;167:115375. doi: 10.1016/j.biopha.2023.115375. Epub 2023 Oct 5.